ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Advanced Search

Change in Hypertension (HTN) Guidelines in Living Kidney Donors (LKDs) and Long-Term Renal Outcomes

M. Merzkani1, A. Denic1, M. D'Costa1, L. Ricaurte1, R. Narasimhan1, X. Benavides1, A. Mullan1, J. Larson1, W. Kremer1, W. Park1, M. P. Alexander1, H. Chakkera2, S. Textor1, S. Taler1, M. Stegall1, N. Issa1, A. Rule1

1Mayo Clinic Rochester, Rochester, MN, 2Mayo Clinic Rochester, Scottsdale, AZ

Meeting: 2020 American Transplant Congress

Abstract number: C-080

Keywords: Donation, Proteinuria, Renal dysfunction

Session Information

Date: Saturday, May 30, 2020

Session Name: Poster Session C: Kidney Living Donor: Long Term Outcomes

Session Time: 3:15pm-4:00pm

 Presentation Time: 3:30pm-4:00pm

Location: Virtual

Related Abstracts
  • Diagnostic Performance of Blood Pressure Measurement Modality in Prospective Living Kidney Donors
  • Metabolic Syndrome Predicts Worse Long-Term Renal Outcomes in Living Kidney Donors (LKDs)

*Purpose: There is limited knowledge regarding the long-term renal outcomes in hypertensive LKDs. We performed a multicenter study assessing long-term outcomes with or without HTN at the time of donation using emerging definitions with both office and ambulatory BP (ABP) readings.

*Methods: We prospectively followed LKDs from 1999 to 2012. We studied all donors who completed the survey or had clinical follow-up between 2017 and 2019. Different definitions of HTN were assessed: h/o of HTN (HxHTN) was defined as a kidney donor with a diagnosis of HTN prior to donor evaluation; antihypertensive medications use (antiHTN meds). Office HTN was defined as having HxHTN or taking antiHTN meds or having office BP ≥ 140/90 (JNC7) or ≥ 130/80 (ACC/AHA 2017). Ambulatory Blood Pressure Monitoring (ABPM) HTN was defined as having HxHTN or taking antiHTN meds or an Active (daytime) ABPM > 135/85 (JNC7) or > 130/80 (ACC/AHA 2017). A non-dipper was defined as the ratio of mean nocturnal and active ABPM greater than 90% for systolic or diastolic readings. Renal outcomes were eGFR<45, 40% decline in eGFR, or proteinuria. Logistic regression was used for analysis, unadjusted and adjusted for age, sex, follow-up time.

*Results: A total of 918 kidney donors who had ABPM were analyzed with a mean 10.6 years of follow-up. As seen in Table 1, none of the HTN definitions and types of measurements were predictor for eGFR<45 ml/min or a 40% decline in eGFR. History of taking antiHTN meds and office HTN by JNC7 predicted proteinuria in the adjusted model. Nondipper status also predicted proteinuria (OR=2.4, p=0.034).

*Conclusions: We did not detect a long-term risk for clinically significant reductions in GFR among hypertensive donors using different definitions of HTN. However, given the increased risk for proteinuria among hypertensive LKDs, longer follow-up is needed to determine its potential clinical impact.

 border=

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Merzkani M, Denic A, D'Costa M, Ricaurte L, Narasimhan R, Benavides X, Mullan A, Larson J, Kremer W, Park W, Alexander MP, Chakkera H, Textor S, Taler S, Stegall M, Issa N, Rule A. Change in Hypertension (HTN) Guidelines in Living Kidney Donors (LKDs) and Long-Term Renal Outcomes [abstract]. Am J Transplant. 2020; 20 (suppl 3). https://atcmeetingabstracts.com/abstract/change-in-hypertension-htn-guidelines-in-living-kidney-donors-lkds-and-long-term-renal-outcomes/. Accessed February 27, 2021.

« Back to 2020 American Transplant Congress

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
      • Penis Transplantation: First U.S. Experience.
      • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
      • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
      • Evidence of a Clinically Significant Drug-Drug Interaction between Cannabidiol and Tacrolimus: A Case Report
      • Kidney Dialysis after Heart Transplantation: The Short and Long Term Outcomes

      Visit Our Partner Sites

      American Transplant Congress (ATC)

      Visit the official site for the American Transplant Congress »

      American Journal of Transplantation

      The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

      American Society of Transplantation (AST)

      An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

      American Society of Transplant Surgeons (ASTS)

      The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

      Copyright © 2013-2021 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

      Privacy Policy

      loading Cancel
      Post was not sent - check your email addresses!
      Email check failed, please try again
      Sorry, your blog cannot share posts by email.
      This site uses cookies: Find out more.